Corporate Development Associate, Lindus
+ Equity
2-5 days a week in office (London Bridge)
Accountable research organization
Job no longer available
Accountable research organization
101-200 employees
Job no longer available
+ Equity
2-5 days a week in office (London Bridge)
101-200 employees
Company mission
To give sponsors confidence and control over their clinical studies.
Role
Who you are
- 2-3 years’ experience at a top strategy or life sciences consultancy, a biotech corporate development or BD team, or an investment role focused on healthcare
- A medical degree, life sciences PhD, or similarly rigorous scientific background is strongly preferred. You can read a clinical data package and hold your own in a scientific discussion
- Strong commercial judgement. You can size a market for a therapeutic asset, conduct an rNPV valuation, pressure-test a commercial thesis, and identify where a therapeutic area is heading
- Excellent Excel and PowerPoint skills. You’re comfortable building peak sales forecasts, competitive benchmarks, and deal economics from scratch, and turning them into clean, persuasive slides
- Clear writer. You can produce concise internal memos and external-facing materials without a lot of editing
- High ownership. You drive work to completion and raise your hand when something is off, rather than waiting to be directed
- AI- and LLM-fluent. You use the latest tools to work faster and better across research, synthesis, modelling support, and presentation development, with strong judgment on where human review matters.
- Genuine interest in drug development, deal-making, and the economics of biotech. You know how to read a patent
- You belong here! If your experience and interests match those above, we want you to apply
What the job involves
- As Associate, Corporate Development, you’ll report directly into our VP Corporate Development and sit at the core of the deal team
- You’ll run the engine of asset evaluation (from screening through to commercial diligence and deal structuring) and help build the materials that shape sponsor, investor, and board conversations
- This is an early-stage role with unusually direct exposure to the Co-CEOs and the people making the decisions
- Running asset identification sprints
- Driving commercial diligence on shortlisted assets, including peak sales modelling, competitive benchmarking, indication prioritisation, and exit pathway analysis
- Supporting scientific and regulatory diligence alongside our CMO and external experts, and coordinating with our external DD partners
- Building the materials that run the deal process: asset briefing docs, first-call question packs, sponsor outreach, and data room review notes
- Preparing investor and board materials, including pitch decks, portfolio summaries, and financial models
- Supporting deal structuring and negotiation alongside the VP Corporate Development, Co-CEOs, and counsel
Application process
- Initial conversation with Sean Sheppard (VP Corp Dev) or Michael Young Co-CEO (30 mins)
- Get to know each other, discuss the role, and answer any questions about Lindus and LTx
- Functional interview with Sean and Michael (Co-CEO) (45 mins)
- Prepared presentation to evaluable your experience and how you’d approach asset diligence and deal work
- Values interview with Meri (Co-CEO) and another member of the wider team (30 mins)
- A chance to get to know each other and explore how our values align
Salary benchmarks
Our take
Traditional clinical research companies are often inefficient and rely upon pen and paper, even for the UK COVID-19 vaccine trial, one of the best-funded trials in history. In addition, the cost of conducting clinical trials has skyrocketed over the last decade. This, of course, stifles innovation and means fewer new treatments for patients.
In response to these challenges, Lindus Health was established with the mission to simplify patient participation in research and expedite the development of novel treatments. On a mission to change how trials are conducted in order to provide faster, safer clinical trials on behalf of companies developing new treatments, and lowering the barriers to participation for patients.
Since launching in 2021, Lindus Health has actively connected patients with clinical trials across diverse domains, encompassing areas such as type 2 diabetes, COVID-19 diagnostics, and mental health. Bolstered by several successful funding rounds, the company is poised to facilitate end-to-end clinical trials and research sponsors with high-quality data. Alongside this growth, Lindus is expanding its workforce. This strategic approach underscores its commitment to reshaping the landscape of clinical research for the betterment of patients and the advancement of medical science.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
66% female employees
Company
Funding (last 2 of 4 rounds)
Jan 2025
$55m
SERIES B
Aug 2023
$18m
SERIES A
Total funding: $78.7m
Company benefits
- 31 paid days off each year, including bank holidays.
- £60 monthly wellness allowance with complete flexibility on how to spend this including opting in to a company private health insurance scheme through AXA, a wellhub membership and more!
- Access to gym and retail discounts through our benefits platform Happl.
- Enhanced Parental Leave - 16 weeks full pay for primary care giver & 6 weeks full pay for secondary care giver
- Cycle to work and other salary sacrifice schemes
- Regular whole company and team events, both in person and virtually!
- £1,000 Learning and Development allowance each year to put towards courses, certifications and development
- A well stocked pantry and drinks fridge, Monday breakfast spread and catered team lunch on a Thursday for the UK office every week!
Company values
- Be transparent: We share information across the whole team, avoiding hierarchies and siloes. No politics!
- Stay curious: Deference to "the way it has always been done" is the biggest thing holding our industry back
- Be high-agency: Nothing happens unless we make it happen. We never assume something is somebody else's responsibility
- Act quickly: Once we’ve made a decision. We win by moving fast
- Benefit patients: Our mission is serious, but we’ll only achieve it if we have fun while we go. Innovation doesn’t take place in a boring environment
Company HQ
Downtown Crossing, Boston, MA
Articles
Leadership
Meri Beckwith
(Co-Founder & Co-CEO)Previously a venture capital investor and partner to biotech and digital health companies including Attest, Latent Logic, Helloself and CoMind.
Michael Young
(Co-Founder & Co-CEO)Previously a Special Adviser to the UK Prime Minister, where they advised the UK government on life sciences. Also a former Management Consultant at McKinsey and LEK.
Share this job